DoxorubicinAntibiotics, AntineoplasticAnthracyclinesNaphthacenesDaunorubicinAclarubicinRazoxaneCarubicinNogalamycinIdarubicinLeukemia P388EpirubicinAntineoplastic Combined Chemotherapy ProtocolsMenogarilAntineoplastic AgentsBreast NeoplasmsCardiotoxinsCyclophosphamideVincristineBridged CompoundsDrug Resistance, NeoplasmP-GlycoproteinHeart DiseasesStreptomycesTaxoidsExtravasation of Diagnostic and Therapeutic MaterialsDrug Resistance, MultipleLeukemia L1210Intercalating AgentsCardiomyopathiesDrug ResistanceVinblastinePaclitaxelDose-Response Relationship, DrugLiposomesMitoxantroneDrug Administration ScheduleTreatment OutcomeDrug CarriersVerapamilHeartDisease-Free SurvivalDNA Topoisomerases, Type IIFluorouracilChemotherapy, AdjuvantEtoposideTumor Cells, CulturedCell Line, TumorDrug Screening Assays, AntitumorPolyethylene GlycolsSurvival AnalysisNeoplasm MetastasisCytarabineCell SurvivalCisplatinNeoplasmsNeoadjuvant TherapyPrednisoneDrug SynergismInfusions, IntravenousRemission InductionApoptosisMethotrexateEpothilonesGlycosides